Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Pharmaceutical Business Review
Return to: PBR Home
Kissei Pharmaceutical Co., Ltd. Kissei Pharmaceutical Co., Ltd. (Kissei) is a pharmaceutical company. It discovers, manufactures and sells of pharmaceutical products. The product portfolio of Kissei include Urief, a treatment for dysuria associated with benign prostatic hyperplasia; Salagen, a therapeutic agent for patients with dry mouth; Epoetin Alfa BS Injection [JCR], a treatment for renal anemia; Glubes, agent for postprandial hyperglycemia. Besides, Kissei manufactures and sells nutritional foods including dietary supplements. The company has manufacturing plants in Matsumoto city and Shiorjiri city. It also operates the distribution, nutritional business and information centers in Shiojiri and Matsumoto city respectively. Apart from Japan, the company operates in the US, the UK and other parts of the world through 12 sales branches and 44 sales offices. Kissei is headquartered in Matsumoto, Japan. Company Data Biocompatibles UK Ltd Biocompatibles UK Limited (Biocompatibles UK) is a medical technology company. It carries out the development, manufacture and selling of implantable embolisation and drug-eluting beads. The company operates in the area of interventional oncology by embolic and drug-device combination products. Biocompatibles UK is principally focused on the commercialization of bead products of BTG International group. The company sells LC Bead (controlled embolization system), LC BeadM1 and Bead Block directly to specialist healthcare physicians in the US; and DC Bead (embolic Drug-Eluting Bead), DC BeadM1 and Bead Block through distributors in other countries. Its products are used in over 70 countries worldwide for treating primary liver cancer, liver metastases from colorectal cancer and other cancers. Biocompatibles UK is a subsidiary of BTG plc and is headquartered in Farnham, Surrey, the UK. Company Data Aceto Corporation Aceto Corporation (Aceto) is a marketer and distributor of pharmaceutical intermediates and active ingredients, and agricultural protection products and specialty chemicals, among others. The company’s core business activities include sourcing, quality assurance, regulatory support, marketing and distribution of chemically derived pharmaceuticals, specialty chemicals, nutraceuticals, and crop protection products. It distributes more than 1,100 chemical compounds and pharmaceuticals to various sectors such as pharmaceutical, agricultural, nutraceutical, coating and general chemical consuming industries. Geographically, the company has a presence in ten countries, namely, China, France, Germany, the Netherlands, India, Hong Kong, Singapore, Japan, the UK and the US. Aceto is headquartered in New York, the US. The business strategy of the company focuses on sourcing and qualifying pharmaceutical intermediates and active ingredients, nutraceutical products, finished dosage form generics, specialty chemicals and agricultural protection products from manufacturers globally. It also aims to provide high quality regulatory support and quality assurance services to its customers and suppliers worldwide. It aims to globalize and expand its nutraceutical packaged dietary supplements business with focus on growth markets to increase the offerings of finished dosage form generic branded products. Company Data STAAR Surgical Company STAAR Surgical Company (STAAR) is a medical device company, based in the US. The company designs, develops, manufactures and sells implantable lenses for the ophthalmic market. Its products include Visian ICL, Visian ICL with CentraFLOW, Visian Toric ICL, Implantable Collamer and Silicone IOLS, Toric IOLS and Acrylic IOLS. The company also manufactures invasive visual implants and intraocular lenses, and medical devices for refractive and glaucoma surgery that are used to correct the vision of patients with cataract and refractive conditions. STAAR also strives to bring improvements in existing intraocular lens models. The company has manufacturing and administrative facilities in the US, Switzerland and Japan. The company has a presence in countries such as India, Singapore, China and France. The company markets its products in more than 60 countries, with direct distribution in North America, Japan, and Spain, and independent distribution in the rest of the countries. STAAR is headquartered in Monrovia, California, the US. Company Data DiaGenic ASA DiaGenic ASA (DiaGenic) is an innovative diagnostic company. It undertakes the development of novel and patient-friendly in vitro diagnostics (IVD) for early detection of diseases. The company specializes in developing blood-based biomarkers for early detection of Alzheimer’s disease (AD). Its gene signatures have diverse applications in the diagnostic work related to AD. The company’s lead product, ADtect is a blood test that helps distinguish mild to moderate AD from the absence of dementia. The company operates through a single business segment that undertakes the research and development of blood-based gene expression tests within the AD area. The company is also developing three AD diagnostic tests, which are in pipeline. DiaGenic is headquartered in Oslo, Norway. Company Data Sartorius AG Sartorius AG (Sartorius) is a Germany-based laboratory and process technology and equipment provider. The company undertakes the manufacture and distribution of laboratory and process technology equipment and its sale to the companies in the pharmaceutical, biotechnology, chemical, food and beverage industries, and numerous research and educational institutes and laboratories in Germany and abroad. The company has production facilities in Europe, Asia and America. It provides its products across the world through a network of sales subsidiaries and local commercial agencies. It operates in Germany and conducts operations in Europe, Asia-Pacific and North America and Rest of the World through its subsidiaries. Sartorius is headquartered in Goettingen, Germany. Company Data Mako Surgical Corp. MAKO Surgical Corp. (MAKO Surgical) is a medical device company. It develops solutions for orthopedic market. The company markets RIO Robotic Arm Interactive Orthopedic System used in joint specific applications for the knee and hip. It also markets proprietary RESTORIS implants, which can be used in orthopedic procedures called MAKOplasty. The product line of the company includes MAKOplasty Partial Knee and MAKOplasty Total Hip Arthroplasty. MAKO Surgical offers its product robotic arm interactive system under the brand, RIO. This interactive system enables surgeons to provide interactive therapy to the patients. The company also offers robotic arm interactive orthopedic system, which utilizes tactile-resistance and patient-specific visualization to prepare the knee joint for the insertion and alignment of resurfacing implants. Its products are used in computer assisted surgery, haptics, robotics and implants. MAKO Surgical is headquartered in Fort Lauderdale, Florida, the US. In September 2013, Stryker Corporation entered into a definitive agreement to acquire the company, for a purchase consideration of $1,650m. Company Data Waters Corporation Waters Corporation (Waters) is a US-based analytical instrument manufacturing company. It carries out the design, production, commercialization and servicing of analytical technologies such as high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC), chromatography columns and chemistry products, mass spectrometry (MS) systems, thermal analysis, rheometry and calorimetry instruments. The company operates in two divisions, namely, Waters Division that supports liquid chromatography and mass spectrometry technologies, and TA Instruments division that supports thermal analysis technologies. The company’s products are widely utilized by pharmaceutical, biochemical, life sciences, industrial, academic and government customers working in research and development, quality assurance and other laboratory applications. Waters is headquartered in Milford, Massachusetts, the US. Company Data Daewoong Pharmaceutical Co., Ltd. Daewoong Pharmaceutical Co., Ltd. (Daewoong Pharma) is a Korean based drug manufacturing and distribution company. It is the leading prescription drugs saling company in Korea. The company's product offering consists of drugs in the forms of tabs, capsules, ointments, injections, liquids and sprays. Daewoong Pharma offers its products for the therapeutic conditions of bone and joint diseases, cardiovascular treatments, central nervous system treatments, circulatory system agents, dermatologic agents, gastrointestinal agents, health supplements, respiratory remedies and others. It also carries out development and commercialization of products through in-licensing, co-marketing and co-promotion. The company holds its presence over the major Asian markets including Indonesia, China, Vietnam,Thailand and India. It operates with fourteen branches in Korea, seven in Asia and one in the US. Daewoong Pharma is headquartered in Seoul, Republic of Korea. Company Data Abbott Laboratories Abbott Laboratories (Abbott) is a global healthcare company. It undertakes the discovery, development, manufacture, and sale of a broad and diversified range of healthcare products including pharmaceuticals, diagnostics, vascular and nutritional products. The company’s pharmaceutical, diagnostic, and nutritional products include specialized medicines; medical diagnostic instruments and tests; minimally invasive surgical devices; a range of nutritional supplements for infants, children and adults; and products for veterinary care. It has research and development, manufacturing and administrative facilities spread across the world. Abbott is headquartered in Abbott Park, Illinois, the US. In January 2013, Abbott's research-based pharmaceuticals business, AbbVie Inc. (AbbVie) got separated from the company. AbbVie is now an independent public company trading under "ABBV" symbol on the New York Stock Exchange. Company Data BioDelivery Sciences International, Inc. BioDelivery Sciences International, Inc. (BDSI) is a specialty pharmaceutical company. The company develops and commercializes products in the areas of pain management and oncology supportive care, including chronic pain, breakthrough cancer pain, opioid dependence, and nausea and vomiting related cancer pain. BDSI's patented drug delivery technologies include: BioErodible MucoAdhesive (BEMA) technology, which consists of a small dissolvable polymer film for application to mucosal membranes for transmucosal delivery of drugs for time critical conditions and Bioral technology, which is based upon a novel process of encapsulating or protecting a drug to facilitate oral dosing of drugs otherwise given by intravenous administration. Its pipeline candidates include BEMA Buprenorphine, BEMA Granisetron and BEMA Buprenorphine/Naloxone. BDSI is headquartered in Raleigh, North Carolina, the US. Company Data JSC Farmak International JSC Farmak International (Farmak) is a pharmaceutical company. The company manufactures and markets finished medicines and pharmaceutical substances to the healthcare markets. Its products portfolio include endocrinology drugs, cold relief / anti-allergy medications, neurological / sedative drugs, cardiac drugs, ophthalmology drugs, gastroenterology medication, drugs for treatment of musculoskeletal system diseases, diagnostic drugs, dermatology/ gynecology drugs and other medications. Farmak offers services, such as production of pharmaceuticals for human medicine, contract manufacturing, scientific research and pharmaceutical substances synthesis. The company operates through its representative offices in Kazakhstan, Uzbekistan, Russian Federation and Kyrgyz Republic. Farmak is headquartered in Kyiv, Kiev, Ukraine. Company Data Helix BioMedix, Inc. Helix BioMedix, Inc. (Helix) is a biopharmaceutical company. It develops diverse proprietary bioactive peptides. It carries out peptide design, synthesis and characterization followed by assay development, screening, tissue culture and microbiology. Helix leverages these bioactive peptides by partnering with contract research organizations and peptide manufacturers. The company develops peptides for the consumer skin care products and prescription products. The peptides developed by the company are used in various applications including, anti-aging skin care, acne treatment, wound healing and other topical anti-infective treatments. Helix markets its products under the brand names, Cerakine, Striking, Apothederm and SmartPeptide. Helix is headquartered in Bothell, Washington, the US. The company seeks to develop new proprietary technologies in anti-infectives, ermatology personal care and cosmeceuticals; and derive revenues from licensing its technologies to third parties. Company Data AorTech International plc AorTech International plc (AorTech) is a medical device company. It undertakes development, manufacture, and commercialization of biomedical polymer technology, components and medical devices. The company provides a broad range of polyurethane materials for applications in cardiovascular surgery, interventional cardiology, cardiac rhythm management, orthopedic, plastic surgery, gastroenterological and urological applications. It offers Elast-Eon biostable polyurethanes used in medical devices for long term implantation; ECSil, biomedical polymers for pacing and neurostimulation leads, spinal disc, and breast implant; and Elast-Eon reaction injection molding (RIM) products. AorTech is headquartered in Surrey, Scotland, the UK. AorTech focuses on the development and protection of its product portfolio through patents and licensing of its products and proprietary technology. The company also focuses on development of a wide span of pipeline products for its medical devices business. Company Data Akorn, Inc. Akorn, Inc. (Akorn) is a niche generic pharmaceutical company. The company carries out the development, manufacturing and commercialization of diagnostic and therapeutic ophthalmic pharmaceuticals; and hospital drugs and injectables. The company's product offer treatment in ophthalmology, antidotes, anti-infectives, pain management, anesthesia, vaccines and others. It also offers contract manufacturing services. Akorn offers these products and services to physicians, surgery centers, clinics, optometrists, hospitals, long-term care, wholesalers, retail pharmacies, group purchasing organizations and other pharmaceutical companies. It operates manufacturing facilities in India and the US. Along with its subsidiaries, the company operates in the US, Mauritius and India. Akorn is headquartered in Lake Forest, Illinois, the US. Company Data Meiji Holdings Co., Ltd. Meiji Holdings Co., Ltd. (Meiji Holdings) is a conglomerate operating in dairy products, confectionery and healthcare and pharmaceutical industries. It undertakes the manufacture and selling of fresh dairy products, powdered milk, condensed milk, butter, cheese, confectioneries, sugar, corn sweeteners, functional healthcare products, ethical pharmaceuticals, agricultural chemicals and veterinary drugs. The company also provides transportation, storage, mechanical engineering services among others. Meiji Holdings principally operates through its two subsidiaries, namely, Meiji Co, Ltd., and Meiji Seika Pharma Co., Ltd. The company has presence in the US, China, India, Australia, Indonesia, Europe, Singapore and Thailand. Meiji Holdings is headquartered in Tokyo, Japan. Company Data Taisho Pharmaceutical Co., Ltd. Taisho Pharmaceutical Co., Ltd. (Taisho) is a Japan-based pharmaceutical company. It carries out the development, manufacture and marketing of various pharmaceutical products. The company’s product portfolio includes a range of prescription pharmaceutical and self-medication (OTC) drugs. Some of its principal prescription pharmaceuticals include Palux injection, a peripheral vasodilator; Clarith, a macrolide antibiotic; Ancaron tablets for the treatment of cardiac arrhythmia; a nonsteroidal anti-inflammatory drug Lorcam tablets; and Solon, an anti-ulcer agent among others. Taisho is a leading company in the field of OTC medicines and markets a range of products on a global scale. Taisho is a subsidiary of Taisho Pharmaceutical Holdings Co., Ltd. and is headquartered in Tokyo, Japan. Company Data Ranbaxy Laboratories Limited Ranbaxy Laboratories Limited (Ranbaxy) is an integrated, research-based, international pharmaceutical company. It undertakes the development, manufacture and commercialization of a wide range of generic medicines. The company’s product portfolio includes active pharmaceuticals ingredients (APIs) and intermediates, formulations, generics, drug discovery and consumer health care products. Ranbaxy’s R&D activities focus on seeking approvals for its products in developed and emerging markets, several of which its incorporate proprietary Novel Drug Delivery Systems and technologies, developed at its own labs. Operating through an international portfolio of affiliates, joint ventures and alliances, ground operations and manufacturing operations, the company serves its customers across the world. Ranbaxy is a member of the Daiichi Sankyo Group and is headquartered in Gurgaon, Haryana, India As a part of its commitment to increase coverage and enhance access to medicines across the world, Ranbaxy is introducing several innovative products in markets, where it has a strong presence. Company Data Japan Tobacco Inc. Japan Tobacco Inc. (JT) is the world's third largest cigarette maker. It manufactures, distributes and sells tobacco products worldwide. Its internationally recognized cigarette brands include Camel, Winston, Mild Seven and Benson & Hedges. JT is also active in pharmaceuticals and foods businesses. The Pharmaceutical division of the company develops drugs for indications such as HIV infection, hepatitis C, dyslipidemia, hyperphosphatemia, type 2 diabetes mellitus, anemia and autoimmune/allergic diseases, while its Food division deals with processed foods, beverages and seasonings. The company has direct operations in more than 70 countries and its products are sold in more than 120 countries. JT is headquartered in Tokyo, Japan. Company Data ViroPharma Incorporated ViroPharma Incorporated (ViroPharma) is a biopharmaceutical company. It develops and commercializes products for the treatment of various serious life threatening ailments. The company’s marketed products include Cinryze, for the treatment of Hereditary Angioedema (HAE); Vancocin, for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus; Buccolam, for the treatment of Pediatric Epilepsy; and Plenadren for treatment of adrenal insufficiency in adults. The product pipeline of Viropharma comprises Cinryze (C1 esterase inhibitor [human]) for management of HEA; VP 20621 for the management of C. difficile infection (CDAD); and VP20629, for the treatment of Friedreich’s Ataxia. The company operates in the US, Belgium, France, Switzerland, Germany and the UK. ViroPharma is headquartered in Pennsylvania, the US. Company Data
1-20 of 1532 results

See all companies